The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
The Food and Drug Administration granted approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
It’s only the second drug that’s been convincingly shown to delay cognitive decline in patients, following last year’s ...
It’s a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial ...
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
Eli Lilly's Kisunla secured standard approval from the U.S. Food and Drug Administration on Tuesday for slowing the ...
SARASOTA, Fla. (SNN) — The Food and Drug Administration has approved a new Alzheimer’s drug from Eli Lilly. According to Eli ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...